Regeneron Pharmaceuticals, Inc.REGNNASDAQ

Revenue CAGR (5Y)

+11.0%

Margin Trend

stable

Free Cash Flow

$4.1B

Profitability

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	16,072	12,173↓24.3%	13,117↑7.8%	14,202↑8.3%	14,343↑1.0%
Gross Profit	13,348	10,468↓21.6%	10,873↑3.9%	12,232↑12.5%	12,242↑0.1%
Operating Income	8,947	5,386↓39.8%	4,349↓19.3%	3,991↓8.2%	3,578↓10.3%
Net Income	8,075	4,338↓46.3%	3,954↓8.9%	4,413↑11.6%	4,505↑2.1%
EBITDA	9,669	5,260↓45.6%	4,693↓10.8%	5,318↑13.3%	5,818↑9.4%
EPS Diluted	71.97	38.22↓46.9%	34.77↓9.0%	38.34↑10.3%	41.48↑8.2%

1 / 2

Values in millions except EPS · Ratios shown as percentages

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance